Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 209,967,793 papers from all fields of science
Search
Sign In
Create Free Account
Endophthalmitis
Known as:
eye inflammations
, EYE INFLAMMATION
, Eye--Inflammation
Expand
Suppurative inflammation of the tissues of the internal structures of the eye frequently associated with an infection.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
19 relations
Conjunctivitis
Eye
Eye Abnormalities
Hypopyon
Expand
Broader (4)
Disorder of eye
Eye Infections
Inflammation
Uveitis
Narrower (1)
Infectious Endophthalmitis
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.
Q. Nguyen
,
David M. Brown
,
+9 authors
J. Ehrlich
Ophthalmology (Rochester, Minn.)
2012
Corpus ID: 13581559
Highly Cited
2011
Highly Cited
2011
The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.
P. Mitchell
,
F. Bandello
,
+8 authors
A. Weichselberger
Ophthalmology (Rochester, Minn.)
2011
Corpus ID: 30655061
Highly Cited
2010
Highly Cited
2010
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema
P. Edwards
Ophthalmology (Rochester, Minn.)
2010
Corpus ID: 29249316
Highly Cited
2009
Highly Cited
2009
Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study.
David M. Brown
,
M. Michels
,
P. Kaiser
,
J. Heier
,
J. Sy
,
T. Ianchulev
Ophthalmology (Rochester, Minn.)
2009
Corpus ID: 7807496
Highly Cited
2006
Highly Cited
2006
Ranibizumab versus verteporfin for neovascular age-related macular degeneration.
David M. Brown
,
P. Kaiser
,
+5 authors
S. Schneider
New England Journal of Medicine
2006
Corpus ID: 43303026
BACKGROUND We compared ranibizumab--a recombinant, humanized, monoclonal antibody Fab that neutralizes all active forms of…
Expand
Review
2005
Review
2005
Acute endophthalmitis following cataract surgery: a systematic review of the literature.
M. Taban
,
A. Behrens
,
+4 authors
P. McDonnell
A M A Archives of Ophthalmology
2005
Corpus ID: 5802736
OBJECTIVES To determine the reported incidence of acute endophthalmitis following cataract extraction over time and to explore…
Expand
Highly Cited
2002
Highly Cited
2002
Intravitreal triamcinolone for refractory diabetic macular edema.
A. Martidis
,
J. Duker
,
+4 authors
C. Baumal
Ophthalmology (Rochester, Minn.)
2002
Corpus ID: 37691250
Review
2001
Review
2001
Corneal blindness: a global perspective.
J. Whitcher
,
M. Srinivasan
,
M. Upadhyay
Bulletin of the World Health Organization
2001
Corpus ID: 13179341
Diseases affecting the cornea are a major cause of blindness worldwide, second only to cataract in overall importance. The…
Expand
Highly Cited
2001
Highly Cited
2001
Childhood blindness in the context of VISION 2020--the right to sight.
C. Gilbert
,
A. Foster
Bulletin of the World Health Organization
2001
Corpus ID: 42765321
The major causes of blindness in children vary widely from region to region, being largely determined by socioeconomic…
Expand
Highly Cited
1995
Highly Cited
1995
Results of the Endophthalmitis Vitrectomy Study. A randomized trial of immediate vitrectomy and of intravenous antibiotics for the treatment of postoperative bacterial endophthalmitis…
A M A Archives of Ophthalmology
1995
Corpus ID: 22037484
OBJECTIVE To determine the roles of immediate pars plana vitrectomy (VIT) and systemic antibiotic treatment in the management of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE